Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression

被引:0
作者
Judy Pang
Kathy A. Toy
Ken A. Griffith
Baffour Awuah
Solomon Quayson
Lisa A. Newman
Celina G. Kleer
机构
[1] University of Michigan Medical School,Department of Pathology
[2] 4217 Comprehensive Cancer Center,Comprehensive Cancer Center
[3] University of Michigan Medical School,Department of Biostatistics
[4] University of Michigan Medical School,Department of Surgery
[5] University of Michigan Medical School,Department of Radiation Oncology
[6] Komfo Anoyke Teaching Hospital (KATH),Department of Pathology
[7] Komfo Anoyke Teaching Hospital (KATH),undefined
来源
Breast Cancer Research and Treatment | 2012年 / 135卷
关键词
African-American; Breast cancer; EZH2; Enhancer of zeste 2; Triple negative; Basal like; Health disparity;
D O I
暂无
中图分类号
学科分类号
摘要
Breast cancer in African-American women has a worse outcome than in Caucasian women. The ancestors of most African-American women come from West Africa, including Ghana. The Polycomb group protein EZH2 is a marker of poor outcome in breast cancers from Caucasian women. The histopathological features and biomarker expression of African breast cancers remain obscure. Here, we investigated a cohort of Ghanaian breast cancers to better define the prevalent tumor types and to test if EZH2 protein may identify aggressive tumors. A group of 169 breast tissues (100 invasive carcinomas and 69 benign) from women treated at Komfo Anoyke Teaching Hospital between 2006 and 2011 were histologically classified and investigated for EZH2 expression. EZH2 nuclear expression we defined as high or low following previously published criteria. Of the 100 invasive carcinomas, 89 % were ductal, 2 % were lobular, and 9 % were metaplastic. Basal-like pathological features were present in 30 % of the tumors. Of the invasive carcinomas, 7 % were grade 1, 41 % grade 2, and 52 % grade 3. EZH2 protein was overexpressed in invasive carcinomas compared to benign breast (p < 0.0001). In invasive carcinomas nuclear EZH2 overexpression was significantly associated with basal-like subtype (p = 0.03) and high histologic grade (p < 0.05). Cytoplasmic EZH2, which has not been previously reported, was present in 16 % of invasive carcinomas and it was associated with triple negative status (p = 0.02). Our results provide the first comprehensive histopathological study of this patient population and uncover the association of EZH2 with high grade and basal-like tumors. We provide the basis for further detailed investigations on this cohort to advance diagnosis and treatment of African and African-American women.
引用
收藏
页码:59 / 66
页数:7
相关论文
共 67 条
  • [1] Smigal C(2006)Trends in breast cancer by race and ethnicity: update 2006 CA Cancer J Clin 56 168-183
  • [2] Eley JW(1994)Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study JAMA 272 947-954
  • [3] Smith-Bindman R(2006)Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med 144 541-553
  • [4] Diaz LK(2007)Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice Adv Anat Pathol 14 419-430
  • [5] Carey LA(2006)Race, breast cancer subtypes, and survival in the carolina breast cancer study JAMA 295 2492-2502
  • [6] Kim MJ(2006)Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes Hum Pathol 37 1217-1226
  • [7] Rakha EA(2008)Basal-like breast cancer: a critical review J Clin Oncol 26 2568-2581
  • [8] Reis-Filho JS(2007)Differences in risk factors for breast cancer molecular subtypes in a population-based study Cancer Epidemiol Biomarkers Prev 16 439-443
  • [9] Ellis IO(2006)Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma Mod Pathol 19 264-271
  • [10] Yang XR(2006)Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast Histopathology 49 22-34